glp-1 cardiovascular outcome trials fig1.png Review of Cardiovascular Outcome Trials

Thus, in perfect agreement with the recent ADA-EASD consensus report [6], we also encourage the adoption of GLP-1RA plus SGLT2i combination therapy in T2DM patients with established ASCVD (coronary artery disease, cerebrovascular disease, or peripheral arterial disease) or multiple risk factors for ASCVD (i.e., age 55 years, obesity, dyslipidemia, hypertension, current tobacco use, left ventricular hypertrophy, and/or proteinuria) whose HbA1c remains suboptimal despite initial treatment with only one of these agents

Cytoprotective Research In vitro studies have documented quantifiable changes in oxidative stress biomarkers and mitochondrial membrane potential parameters across cellular integrity research models

This suggests epitalon's effects extend beyond simple telomere maintenance to affect how genes are expressed across multiple cellular systems

Once the GH pulse has occurred, you are free to eat according to your specific dietary protocol

PMID 27549768